-
AN AUTOMATED FEASIBILITY ASSESSMENT TOOL FOR INDIRECT TREATMENT COMPARISONS ACROSS MULTIPLE ANALYTICAL METHODS
Mar 18, 2026, 21:38 PM -
COST OF ILLNESS AMONG ALZHEIMER’S DISEASE AND RELATED DEMENTIAS (ADRD) MEDICARE PATIENTS IN THE UNITED STATES BETWEEN 2011-2021
Mar 18, 2026, 21:38 PM -
FROM EVIDENCE TO PRICE: EMBEDDING PRICING STRATEGY IN EARLY MARKET ACCESS PLANNING
Mar 18, 2026, 21:38 PM -
PREFERENCES AND TRADE-OFFS FOR MASLD/MASH TESTING AMONG PATIENTS WITH TYPE 2 DIABETES: A DISCRETE CHOICE EXPERIMENT
Mar 18, 2026, 21:38 PM -
BURNOUT AMONG EMERGENCY CARE STAFF IN HUNGARY: PREVALENCE AND INTERVENTION POSSIBILITIES - A QUASI-EXPERIMENTAL STUDY
Mar 18, 2026, 21:38 PM -
BREAST CANCER PATTERNS AND TREATMENT ACCESS IN DENMARK: IDENTIFYING OPPORTUNITIES FOR DECENTRALIZED CARE IN BREAST CANCER CARE (HEATMAP-ONKO-BREAST)
Mar 18, 2026, 21:38 PM -
A LANDSCAPE ASSESSMENT OF THE STATISTICAL AND ECONOMIC MODELING OF CURE IN ONCOLOGY
Mar 18, 2026, 21:38 PM -
ACCESS TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ANTIOBESITY MEDICATIONS: FORMULARY COVERAGE AND PRIOR AUTHORIZATION RESTRICTIONS ACROSS U.S. PAYERS
Mar 18, 2026, 21:38 PM -
QUANTIFYING CDA-INESSS DIFFERENCES IN ONCOLOGY HTA: RECOMMENDATIONS, RE-ANALYSIS, AND PRICE REDUCTIONS (2024-2025)
Mar 18, 2026, 21:38 PM -
TRENDS IN PCSK9 INHIBITOR COSTS, COST SHARING, AND ADHERENCE AMONG MEDICARE BENEFICIARIES FOLLOWING 2018 PRICE REDUCTIONS
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON GLP-1 THERAPIES FOR OBESITY: REAL-WORLD EXPERIENCES AND TREATMENT NARRATIVES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INAVOLISIB IN THE TREATMENT OF PIK3A-MUTATED, HR+/HER2-ABC LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN THE US
Mar 18, 2026, 21:38 PM -
NOVEL PATIENT-CENTERED APPROACH TO CLINICAL TRIAL READINESS IN RARE DISEASES
Mar 18, 2026, 21:38 PM -
HETEROGENEOUS RESPONSES TO BRAZIL’S PHARMACEUTICAL PRICE CAP REGULATION: EVIDENCE FROM PRIVATE INSURANCES AND THE UNIFIED HEALTH SYSTEM
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A MULTI-AGENT "DEEP" AI SYSTEM FOR HEOR EVIDENCE AND INTELLIGENCE GENERATION
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF DPYD-GUIDED FOLFOX IN UNRESECTABLE METASTATIC COLORECTAL CANCER IN THE US: A PATIENT-LEVEL MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE GLOBAL ECONOMIC BURDEN OF HEPATITIS DELTA VIRUS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-WORLD CONCORDANCE WITH THE FRAMINGHAM STROKE RISK MODEL IN ATRIAL FIBRILLATION AND IDENTIFICATION OF ADDITIONAL SIGNIFICANT FEATURES
Mar 18, 2026, 21:38 PM -
TEMPORAL TRENDS AND PREDICTORS OF FIRST-LINE CHEMOTHERAPY AMONG OLDER WOMEN DIAGNOSED WITH TRIPLE-NEGATIVE BREAST CANCER IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
GLOBAL ASSESSMENT OF THE DIAGNOSED PREVALENCE OF CROHN’S DISEASE AND ULCERATIVE COLITIS IN PEDIATRIC POPULATIONS
Mar 18, 2026, 21:38 PM
